Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-21-044007

Options or other derivatives

  • Director acquired 7,728 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MOTT DAVID M Director 2021-06-29 Grant or award · Stock Option (right to buy) +7,728 7,728 D
Loading xslF345X03/doc4.xml…